gip/glp-1 ra Frontiers Updated guidance from the PCDS

A total of 74 oocytes were vitrified without the addition of GSH (P0), resulting in 39 oocytes surviving (51.27.0)%, 10 with zona pellucida fractures (14.45.1)%, 15 with cytoplasmic shrinkage (20.86.7)%, and 10 with cytoplasmic lysis (13.65.2)%

In the STEP UP clinical trial, the 7.2-mg dose demonstrated a mean weight loss of 20.7% at 72 weeks, compared with a reduction of 17.5% with the previously approved semaglutide (Wegovy) injection (2.4 mg) and 2.4% with placebo

Comment on impact of GLP-1 agonists and SGLT-2 inhibitors on diabetic retinopathy progression: an aggregated electronic health record study

(PubMed) Natural Medicines